Stoke Therapeutics Inc at JPMorgan Healthcare Conference Transcript
Great. Welcome, everyone. My name's Jess Fye. I'm a biotech analyst at JPMorgan, and we are continuing the 44th Annual Healthcare Conference with Stoke.
First, you're going to hear a presentation from the company, and then we're going to get into some Q&A. (Event Instructions)
But with that out of the way, let me pass it over to the company's CEO, Ian Smith.
Thank you, Jess. And good afternoon and good evening to some of those that may be listening on webcast over on the East Coast. I want to say thank you to my friends and family that appear to have shown up in the room today to fill some seats. So, welcome to you all. Those include investors and analysts as well, but thank you to my friends and family, they're here.
My name's Ian Smith. I'm the CEO of Stoke Therapeutics. I've been in the role since March of 2025. And I want to tell you, spend the next 20 minutes giving you a brief
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
